Weiguo Ye - Apr 1, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Chief Operating Officer
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Weiguo Ye
Stock symbol
GYRE
Transactions as of
Apr 1, 2025
Transactions value $
$37,500
Form type
4
Date filed
5/14/2025, 08:21 PM
Previous filing
Apr 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ye Weiguo Chief Operating Officer C/O GYRE THERAPEUTICS, INC., 12770 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO /s/ Ruoyu Chen, as attorney-in-fact for Weiguo Ye 2025-05-14 0001985496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GYRE Common Stock Options Exercise $37.5K +50K +7.69% $0.75 700K Apr 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Options Exercise $0 -50K -4.93% $0.00 965K Apr 1, 2025 Common Stock 50K $0.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are vested in full.